COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. Rhode Island patients with a documented clinical need may be eligible for compounded tirzepatide.
Rhode Island’s compact size and proximity to Boston give residents strong healthcare access. Compounding Finder helps Rhode Island patients compare licensed pharmacies.
Yes. The Rhode Island Board of Pharmacy oversees compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.